Search
Cephalexin
go.drugbank.com/drugs/DB00567ApprovedInvestigationalVet approved[A179083,L6547] Cephalexin was approved by the FDA on 4 January 1971.[L6547]
Synonyms: (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidProducts: LUPICEFF ER, CEFALON ® ERAllopurinol
go.drugbank.com/drugs/DB00437ApprovedInvestigationalThis disease has been well-documented in historical medical records and appears in the biographies of several prominent, historically recognized individuals [A175942]. … It was initially approved by the FDA in 1966 [L5674] and is now formulated by several manufacturers [L5677].
Products: ALLOPURINOLO EGTetracycline
go.drugbank.com/drugs/DB00759ApprovedInvestigationalVet approvedWithdrawnIt exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. … The FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml.
Products: PIPERACILLINA E TAZOBACTAM EGAmivantamab
go.drugbank.com/drugs/DB16695ApprovedInvestigational[A235133] Amivantamab was granted FDA approval on 21 May 2021,[L34193] followed by the approval by the EMA on 9 December 2021 [L41474] and Health Canada on 30 March 2022. … FDA approved the subcutaneous formulation, RYBREVANT FASPRO™, across all existing and expanded indications of amivantamab, including its use as a first-line, chemotherapy-free combination regimen with
Doxazosin
go.drugbank.com/drugs/DB00590ApprovedInvestigational[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285] … Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension.
Categories: Drugs Used in Benign Prostatic HypertrophyProducts: DOXAZOSINA EGFamotidine
go.drugbank.com/drugs/DB00927ApprovedInvestigational[L11166] While oral formulations of famotidine are more commonly used, the intravenous solution of the drug is available for use in hospital settings.[L11142] … disease, famotidine was about 20 to 50 times more potent at inhibiting gastric acid secretion than [cimetidine] and eight times more potent than [ranitidine] on a weight basis.
Synonyms: N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide, 3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamideProducts: FAMOTIDINA EGGreen tea leaf
go.drugbank.com/drugs/DB14307InvestigationalGreen tea leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Synonyms: Camelliae Sinensis Non Fermentatum Folium, Matcha TeaEsomeprazole
go.drugbank.com/drugs/DB00736ApprovedInvestigationalincreased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life. … [A177577, A177580] Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread.
Categories: Antiinflammatory and Antirheumatic Products, Non-SteroidsInternational brands: ES-ODCalcium Phosphate
go.drugbank.com/drugs/DB11348ApprovedInvestigationalCalcium phosphate is typically available as an over the counter supplement, antacid, or as an added ingredient in some toothpastes [FDA Label] [L851].
Mixtures: Multivitamines Et Mineraux, Multivitamines Et Mineraux Junior RegulierCategories: Compounds used in a research, industrial, or household settingSildenafil
go.drugbank.com/drugs/DB00203ApprovedInvestigationalAlthough the medication has historically been most popularly recognized as Pfizer's brand name Viagra, sildenafil is currently available generically and even as a non-prescription over the counter medication … in some countries [L5656].
Categories: Drugs Used in Erectile DysfunctionProducts: SILDENAFIL EG, SILDENAFIL EG STADA ITALIA